Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan

NCT06108063 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Knee Arthroplasty, Total

Interventions

DRUG: Losartan
DRUG: Placebo - Losartan

Sponsor

Steadman Philippon Research Institute